Tony,
I should have added that directly following Watts presentation is a presentation by Dr Timmerman from Pepscan Therapeutics titled Peptide Lead Optimisation using Solid-Phase Peptide Arrays.
You have spoken about synthetic array libraries so I know you would be particularly interested.
Interesting to re-quote Dr Wim Mol CEO of Pepscan from 10 May 2011;
"[Pepscan] therefore believes that this agreement [with Phylogica in relation to peptide lead optimisation] only forms the start of a promising and productive relationship between our two companies."
Wayne.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.010(0.79%) |
Mkt cap ! $729.0M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.26 | $1.19 | $322.7K | 264.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1132 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4633 | 4 |
View Market Depth
| Last trade - 13.37pm 29/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |